Crispr Therapeutics (NASDAQ:CRSP) Notches Up on World-First Therapy - TipRanks.com

Great news emerged out of biotech stock Crispr Therapeutics (NASDAQ:CRSP), particularly for those who suffer from sickle-cell anemia. A new treatment for the disease was created using the genetic modification tool, and it’s given Crispr stock a boost, up nearly 5% in Tuesday morning’s trading…#crisprtherapeutics #unitedkingdom #exacel #samarthkulkarni #moderatebuy #crsp #holds
Source: Reuters: Health - Category: Consumer Health News Source Type: news